Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
British Journal of Haematology|July 27, 2005
Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host diseaseD R Couriel, R Saliba, M P Escalón, et al.
Blood|December 1, 1996
Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantationD Przepiorka, C Ippoliti, I Khouri, et al.
Bone Marrow Transplantation|October 12, 1999
Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantationD Przepiorka, I Khouri, C Ippoliti, et al.
Blood|December 12, 2001
Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortalityI F Khouri, R M Saliba, S A Giralt, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 18, 2000
Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1D Przepiorka, R Saliba, K Cleary, et al.
Bone Marrow Transplantation|April 5, 2005
Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: low transplant-related mortality and impact of intensity of conditioning regimenP Anderlini, R Saliba, S Acholonu, et al.
Bone Marrow Transplantation|May 4, 2004
Analysis of 96 patients with advanced ovarian carcinoma treated with high-dose chemotherapy and autologous stem cell transplantationM L Donato, A Aleman, R E Champlin, et al.
Cytotherapy|April 30, 2010
Long-term outcome of a phase II study of BM transplants, partially depleted ex-vivo of CD5-positive and CD8-positive T-lymphocytes in unrelated and related donor 1 antigen mismatched recipientsJ L Gajewski, S Nimer, R M Saliba, et al.
Bone Marrow Transplantation|June 13, 2000
High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancerM L Donato, D Gershenson, C Ippoliti, et al.
Leukemia & Lymphoma|March 8, 2000
Intensive dose ifosfamide and etoposide with G-CSF for stem cell mobilization in patients with non-Hodgkin's lymphomaM L Donato, R E Champlin, K W Van Besien, et al.
Pageof 5